key: cord-0990151-slvz0vq3
authors: Karlebach, Guy; Aronow, Bruce; Baylin, Stephen B.; Butler, Daniel; Foox, Jonathan; Levy, Shawn; Meydan, Cem; Mozsary, Christopher; Saravia-Butler, Amanda M.; Taylor, Deanne M.; Wurtele, Eve; Mason, Christopher E.; Beheshti, Afshin; Robinson, Peter N.
title: Betacoronavirus-specific alternate splicing
date: 2022-01-22
journal: Genomics
DOI: 10.1016/j.ygeno.2022.110270
sha: cebd221bd32bcc7c7685704b4e3bb85798c3843b
doc_id: 990151
cord_uid: slvz0vq3

Viruses can subvert a number of cellular processes including splicing in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumonia, HCV, Zika virus, Dengue virus, influenza H3N2, and RSV. We show that genes showing differential alternative splicing in SARS-CoV-2 have a similar functional profile to those of SARS-CoV and MERS and affect a diverse set of genes and biological functions, including many closely related to virus biology. Additionally, the differentially spliced transcripts of cells infected by coronaviruses were more likely to undergo intron-retention, contain a pseudouridine modification and a smaller number of exons as compared with differentially spliced transcripts in the control groups. Viral load in clinical COVID-19 samples was correlated with isoform distribution of differentially spliced genes. A significantly higher number of ribosomal genes are affected by differential alternative splicing and gene expression in betacoronavirus samples, and the betacoronavirus differentially spliced genes are depleted for binding sites of RNA-binding proteins. Our results demonstrate characteristic patterns of differential splicing in cells infected by SARS-CoV-2, SARS-CoV, and MERS. The alternative splicing changes observed in betacoronaviruses infection potentially modify a broad range of cellular functions, via changes in the functions of the products of a diverse set of genes involved in different biological processes.

Coronavirus SARS-CoV-2 emerged in late 2019 as the third human coronavirus identified in the 21st century. Coronavirus disease 2019 (COVID-19) affects diverse organ systems, including the lungs, digestive tract, kidneys, heart, and brain and is associated with extremely including 6 structural non-coding RNAs and 142 mRNAs. A highly specific interaction was shown between the SARS-CoV-2 NSP16 protein and human U1 and U2 snRNAs, which hybridize to the 5' splice site and to the branchpoint, respectively [14] . NSP16 is an RNA cap modifying enzyme with methytransferase activity that modifies viral RNAs [15] . It was shown that NSP16 additionally suppresses host mRNA splicing. SARS-CoV-2 infection and transfection with NSP16 result in an increase in intron retention in multiple IFN-responsive genes, thereby suggesting a role in splicing in suppressing the host interferon response to SARS-CoV-2 infection [14] . Another non-structural protein, NSP1, whose homologs in SARS-CoV and MERS-CoV have roles in viral replication, translational inhibition, transcriptional inhibition, mRNA degradation, and cell cycle arrest, was shown to contribute to global inhibition of host protein translation and manipulating translation [16, 17, 18] ; in contrast, the translation of SARS-CoV-2-encoded subgenomic RNAs, which contain a common 5' leader sequence that is added during negative-strand synthesis is not suppressed. NSP8 and NSP9 bind to the 7SL RNA component of the signal recognition particle (SRP) and interfere with protein trafficking to the cell membrane upon infection. NSP8 and NSP9

appear to be involved in suppression of the interferon response, which is dependent upon the SRP pathway for transport [14] .

Here, we present a comprehensive survey of alternative splicing associated with infection by betacoronaviruses. We process RNA Sequencing data from multiple datasets of SARS-CoV-2, SARS-CoV, and MERS to reconstruct gene isoform counts, and perform differential expression and differential splicing analysis using the count matrices. The results are integrated using high-level enrichment analysis that includes GO, RBP-binding site and RNA modification enrichment. As a reference, we perform the same analysis using six other viruses and Streptococcus pneumonia. This contrast allows us to show associations of betacoronavirus infection with a number of cellular parameters, affecting genes involved in a wide range of biological functions.

and Respiratory Syncytial Virus. All these datasets were downloaded from the National Center for Biotechnology Information's (NCBI) Short Read Archive (SRA) [19] . Infection of cell lines or primary cells with virus is a commonly used experimental system to investigate host dependency factors and host restriction factors [20] . 

For each cohort listed in Table 1 , RNA-seq data were obtained from the NCBI SRA resource [19] . Except for the nasal swab (SARS-CoV-2-A) dataset [27] , all datasets were processed using a snakemake pipeline that performs the following steps: samples are downloaded from the SRA, quality-control is performed using fastp [30] , alignment to Genome Reference Consortium Human Build 38 version 91 is done using STAR [31] , and isoform quantification carried out by RSEM [32] .

Raw RNA sequence data from the nasopharyngeal swab samples (SARS-CoV-2-A) were generated as described [27] . Reads classified as human using Kraken2 [33] were processed as 

We used HBA-DEALS [36] to calculate the probabilities of differential expression and differential splicing. HBA-DEALS automatically determines the hierarchy of the covariates  and  -they are either in the same model layer and predict isoform expression, or  is in a separate layer that predicts gene expression separately. The choice is made by computing a Bayes factor that compares the two models in a sample of genes, and selecting the model favored by the majority of Bayes factors. For accounting for multiple comparisons we use a Bayesian approach [37] . The prior for  and  is a mixture of two Dirichlet or two Gaussian components, respectively. The first component has a very large variance and it corresponds to differentially expressed or differentially spliced genes, where little is known about the effect size a-priori. The second component has a very small variance and is centered around 0 for  and around HBA-DEALS is freely available at https://www.github.com/TheJacksonLaboratory/HBA-DEALS.

We implemented a version of the Ontologizer [39] analysis code in our Java library phenol (https://github.com/monarch-initiative/phenol). We used the term-for-term GO enrichment analysis with Benjamini-Hochberg correction to select enriched GO terms with FDR  0.05

We used the Ensembl transcript IDs of isoforms included in the study to retrieve the transcript_biotype field from Biomart [40] for each differentially spliced isoform. The proportion of retained intron isoforms is then the number of 'retained_intron' biotypes divided by the total number of biotypes.

For each transcript, the number of exons in the GTF file Homo_sapiens.GRCh38.91.gtf were counted, and the mean number of exons of differentially spliced isoforms was calculated for each dataset. The SARS-COV-2 nasal swab (NSPP) dataset was aligned to the genome using Homo_sapiens.GRCh38.100.gtf, and therefore for this dataset we used this GTF file for counting the number of exons of each isoform.

Supplemental File S2 presents a ranking of genes according to the degree of differential alternative splicing observed in our experiments. The score reflects the degree to which a gene shows more alternative splicing in the betacoronavirus samples than in the control samples. The

In this study, we have performed an in-depth analysis using publicly available RNA-seq data representing experimental and clinical samples of human cells or tissues infected by a range of viruses and bacteria in order to characterize the biological processes that are affected by differential gene expression (DGE) and differential alternative splicing (DAS) during SARS-CoV-2, SARS-CoV, and MERS infection and compared them to changes during infection by other viruses and bacteria.

In this study, we analyzed RNA-seq datasets representing experimental or clinical studies of SARS-CoV-2, SARS, MERS, four other viruses, and Streptococcus pneumonia (Table 1) . We reasoned that although differences in experimental design and sample preparation preclude comparisons between individual datasets, a global analysis of profiles of genes and isoforms in each dataset could be used to generate hypotheses about characteristic functional profiles induced by alternative splicing in samples infected with viruses. We therefore performed Gene Ontology (GO) term enrichment analysis on each dataset and created a heat plot for all GO terms in which the BH-corrected p -value was less than 0.05 in at least two datasets; a total of 1,044 such terms were identified (Supplemental Figures ??-??) . Out of 1,044 terms that were enriched in at least two datasets, 1,025 terms showed a high degree of enrichment in at least one betacoronavirus dataset with respect to DAS. 130 of these terms had a median score below threshold (Supplemental SARS-CoV-2 infection is reported to disrupt both translation and RNA splicing [14] . We therefore asked if the functional profile of DAS genes is enriched for Gene Ontology (GO) terms related to translation and RNA binding. We found that SARS-CoV-2, NSP1, NSP2, SARS, and MERS datasets showed enrichment for both translation (GO:0006412) and RNA binding (GO:0003723) and that the degree of enrichment was correlated ( Figure 2 ). Table 1 .

We performed a similar analysis for differentially expressed genes ( Figure 3 ). The terms

showing enrichment in multiple betacoronavirus samples included terms directly related to viral infection including viral gene expression, as well as biological processes known to be involved in the cellular response to selected viral infections, including mRNA splicing and spliceosomal complex [41, 42, 43] , protein localization to endoplasmic reticulum with a possible relation to endoplasmic reticulum stress [44] , cytosolic ribosome [45] , and translation [46] . Several of these GO terms were also enriched for differentially expressed genes ( Figure 3 ). 

SARS-CoV-2 infection was previously shown to suppress global mRNA splicing [14] . We therefore hypothesized that infection with any of the betacoronaviruses could induce a greater degree of intron retention. We analyzed the mean proportion of intron-retention isoforms among all genes showing DAS and showed a significantly higher degree of intron retention in the betacoronavirus samples (Fig 4A) . Additionally, the mean number of exons in isoforms that were significantly differentially spliced in the betacoronaviruses was lower (Fig 4B) . 

Various ribosomal proteins (RPs) have been shown to participate in viral protein biosynthesis and regulate the replication and infection of virus in host cells [45] . We investigated whether the proportion of ribosomal genes displaying DAS and DGE differed between the betacoronavirus and other datasets. We found a significantly higher proportion of ribosomal genes that displayed DAS in the betacoronavirus samples (Fig. 5A) .

A similar result was obtained for the proportion of ribosomal genes that were differentially expressed ( = 0.004 p , Mann-Whitney-test, Fig. 5B ). It has been previously reported that the J o u r n a l P r e -p r o o f Journal Pre-proof SARS-CoV-2 NSP1 protein can interfere with translation [47, 14] . Our findings support the conclusion that betacoronavirus infection involves or results in regulatory changes in the transcription of ribosomal genes. 

Pseudouridine is an RNA modification that has been shown to affect splicing [48] . Using the RBM database of RNA modifications [49] , we calculated enrichment of RNA modifications in the datasets of this study and compared enrichment in DAS genes of betacoronaviruses and other pathogens. Figure 6 

In order to investigate the mechanisms that determine the observed alternative splicing patterns, we calculated the number of binding sites of RNA Binding Proteins (RBPs) in the sets of differentially spliced genes. For this purpose, we downloaded all RBP targets in the human genome from oRNAment [50] . For each RBP binding site, we determined the p-value of observing an identical or higher/lower number of differentially spliced genes among its targets using the hypergeometric test, and corrected the results using Benjamini-Hochberg multiple testing correction. There were 296 RBP binding sites that were enriched for differentially spliced genes over all betacoronavirus datasets, compared to 686 in the other datasets ( Figure 7A ). Furthermore, there were 687 RBP binding sites whose target sets were depleted of differentially spliced genes in the betacoronavirus datasets, compared to 36 in the other datasets ( Figure 7B ). 

We tested the correlation between the fraction of viral RNA and the proportion of counts of the different isoform of each differentially spliced gene in the SARS-COV-2-A dataset [27] . For each isoform fractions we performed a Kendall correlation test between the viral load and 10 () log p  for isoforms that belong to DAS genes, and for isoforms of non-DAS genes. Isoforms of DAS genes are more highly correlated with viral load than isoforms of non-DAS genes (Fig. 8 ).

An example for two isoforms of ADAR is shown in Supplemental Figure ? ?. ADARs (adenosine deaminases that act on RNA) target double-stranded RNA (dsRNA)

for deamination of adenines into inosines, and act during viral infections to produce hypermutation of the viral RNA or to edit host transcripts that modulate the cellular response. ADARs have been

show to be involved in coronavirus genome editing [53] . We find that the overall expression of ADAR is increased in COVID-19 patient samples as compared to controls, and in addition, isoforms containing two Z-DNA binding domains are increased whereas an isoform expressing only one such domain is decreased. The shorter isoform with one Z-DNA binding domain is constitutively expressed. The longer isoform is expressed in response to interferon from a different promoter [54] . The smaller isoform is almost exclusively found in the nucleus while the larger is expressed in the cytoplasm [55] (Fig. 9 ). The expression of NCOA7 was significantly increased. The short isoform of NCOA7 is inducible by interferon  and may play a role in resistance to inflammation-mediated oxidative stress [56] . In our study, the short isoform showed a tendency towards increased expression and the long isoform was significantly underexpressed.

OAS2, which was previously shown to be highly overexpressed in lung adenocarcinomal cells infected with SARS-CoV-2 [57] , displayed a fold change of 7.11 in the NSPP samples. In addition, a short isoform was a substantially underexpressed compared to the long isoform. The three oligoadenylate synthetases play critical roles in cellular innate antiviral response [58] . The longer isoform of OAS2 contains two oligoadenylate synthase domains, while the short form contains only one (Supplemental Fig. ??) . [45] .

A number of genes were found by HBA-DEALS analysis to be not differentially expressed but to show differential splicing, including CLSTN1, G3BP1, and SMAD3. CLSTN1 encodes calsyntenin, which mediates transport of endosomes along microtubules in neurons as well as mediating intracellular transport of endosomes in HCV-infected cells, thereby contributing to the early stages of the viral replication cycle [59] . A long isoform of CLSTN1 showed increased expression in the clinical samples (Supplemental Fig. ??) . G3BP1 encodes Ras GTPase-activating protein-binding protein 1, an ATP-and magnesium-dependent helicase that plays an essential role J o u r n a l P r e -p r o o f in innate immunity that was shown to play an antiviral role against porcine epidemic diarrhea virus, which is a single-stranded, positive-sense RNA virus that belongs to the Coronaviridae [60] .

Alternative splicing in clinical samples is a shift to the shorter isoform, which lacks a RNA recognition motif (RRM) domain (Supplemental Fig. ??) . SMAD3 encodes an intracellular effector of gene expression responses to TGF- , which can be transcriptionally induced following a number of different viral infections and may promote survival and growth of intracellular pathogens [61] . The SARS-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor- signaling [62] . In the clinical samples, we noted a shift to a non-coding SMAD3 isoform (Supplemental Fig. ??) .

Supplemental 

Our study has shown widespread differential alternative splicing associated with IFI16C not including exons "7" (exon 8 of ENST00000295809.12, exon id ENSE00003481880) and 7a [67] . IFI16 can thus contain one, two, or three copies of highly conserved 56-amino acids serine-threonine-proline (S/T/P)-rich spacer region. IFI16 was shown to influence both glucocorticoid receptor (GR) transactivation and transrepression via an interaction that was specific to the B isoform [68] . The IFI16 B isoform has been reported to be selectively up-regulated in the inflammatory disease systemic lupus erythematosus [69] . It is not always straightforward to use information like this to interpret findings from RNA-seq studies. Currently, a total of 14 IFI16 isoforms are registered in Ensembl. We observed differential splicing for isoforms that correspond to isoform A and isoform C in the older literature ( Figure 10 ). It is currently unknown whether isoforms with three (A) or one (C) copy of the spacer region have specific functionality. Our findings suggest that the cellular response to SARS-CoV-2 infection in the lung involves both upregulation of IFI16 as well as a shift from isoforms with one spacer region to isoforms with three copies. This, and many other similar findings illustrate both the limits of our knowledge of the biological roles of alternative splicing and highlight targets for hypothesis driven research on the functions of differentially spliced isoforms. 

Our current data on ADAR must be viewed in the context of the complex, multi-tasking role that this protein plays in immune responses in viral infections and cancer and how the splicing variants we identify factor into these roles. ADAR forms can be important, through interactions with multiple other proteins for controlling levels and directions of immune changes [55, 70] . Key examples include that ADAR has been recently emphasized as important for causing immune suppression and the mechanisms are still being defined [55, 70] . In this regard, ADAR balances self-tolerance and immune activity by modulating canonical antiviral pathways induced by dsRNA [71] . Adenosine to inosine editing or binding of the cytoplasmic ADAR1 isoform p150

and/or the nuclear p110 to dsRNA prevents prevents detection of dsRNA by cytoplasmic antiviral signaling pathways via interactions with the RIG-I like receptor, OAS/RNAseL, and PKR pathways [55] . This role can be directed towards dsRNA species of viral origin, or, with reduced ADAR levels, endogenous dsRNAs including from inverted Alu repeats and particularly from dsRNAs residing in mitochondria [55] . In fact, control of inflammasome signaling can be controlled in mitochondria by effects of ADAR on activity of a key protein CMPK2 (PKR). Prior studies have shown that ADAR1 can inhibit viral RNA mediated PKR activation [72] and more recently levels of ADAR have been shown to block the action of CMPK2 in accelerating inflammasome signaling [73] . Further, in viral infections, ADAR is involved in immune antiviral signaling, through regulation of IFN-I production and induction of cellular translation arrest, and apoptosis [72, 73] . These latter activities must be tightly regulated in order to not create an environment that favors virus replication. Finally, it has been proposed that ADAR plays a ‘dual' protective role against autoinflammatory disease by regulating ‘IFN production' and the response to IFN. This is especially apparent when ADAR is mutated in a form of childhood "interferonopathy" wherein there is resultant increase in MDA5-mediated ‘IFN production' in specific cell types such as neuronal lineage, probably explaining resultant severe neuropathology [73] .

In addition to providing a comprehensive atlas of genes showing differential splicing be related to the global suppression of mRNA splicing thought to be due to NSP16 binding to the mRNA recognition domains of the U1 and U2 splicing RNAs [14] . We additionally showed that DAS genes identified in coronavirus-infected samples tend to have a lower number of exons than DAS genes in the control groups. We have no mechanistic explanation for this observation.

Specific preference for differential splicing targets possibly evolved as the virus adapted to its host [74] . Recent work has described the rapid emergence of S-protein variants, suggesting viral protein on the host could be optimized within small evolutionary trajectories [75, 76, 77, 78, 79] .

In summary, our study provides a comprehensive atlas of genes showing differential alternative splicing associated with infection by SARS-CoV-2, other betacoronaviruses, and a control set of unrelated viruses. Differential alternative splicing occurs in a diverse range of genes that perform a broad range of functions. We found characteristic enrichment of functions related to mRNA binding and splicing, gene expression, and endoplasmic reticulum, among other functions.

Our study identified a number of associations that may provide hypotheses for future targeted studies, including increased intron retention, depletion of RBP binding sites in differentially spliced genes, and association of exons affected by alternative splicing with several RNA modifications, and an association of genes affected by alternative splicing with ribosomal complexes.

Support for this work was provided by the Donald A. Roux family fund. A.B. was supported by supplemental funds for COVID-19 research from Translational Research Institute of 

COVID-19 pathophysiology: A review

Multiorgan and Renal Tropism of SARS-CoV-2

Pathophysiology, transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19): A review

Alternative splicing as a regulator of development and tissue identity

Expansion of the eukaryotic proteome by alternative splicing

Identification of MAVS splicing variants that interfere with RIGI/MAVS pathway signaling

Roles of RIG-I N-terminal tandem CARD and splice variant in trim25-mediated antiviral signal transduction

A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity

The Dengue virus NS5 protein intrudes in the cellular spliceosome and modulates splicing

Novel splice variants of human ikk negatively regulate ikk -induced irf3 and nf-kb activation

Herpes simplex virus-1 induces expression of a novel MxA isoform that enhances viral replication

Inhibition of U snRNP assembly by a virus-encoded proteinase

Influenza virus NS1 protein-RNA interactome reveals intron targeting

SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses

Crystal structure and functional analysis of the SARS-coronavirus rna cap 2'-O-methyltransferase nsp10/nsp16 complex

Mechanisms of coronavirus nsp1-mediated control of host and viral gene expression

Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation

Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression

The sequence read archive

Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells

Competing endogenous rna network profiling reveals novel host dependency factors required for MERS-CoV propagation

Microinvasion by Streptococcus pneumoniae induces epithelial innate immunity during colonisation at the human mucosal surface

Combined analysis of metabolomes, J o u r n a l P r e -p r o o f Journal Pre-proof proteomes, and transcriptomes of hepatitis C virus-infected cells and liver to identify pathways associated with disease development

2', 5'-oligoadenylate synthetase 2 (OAS2) inhibits Zika virus replication through activation of type I IFN signaling pathway

RNA sequencing of H3N2 influenza virus-infected human nasal epithelial cells from multiple subjects reveals molecular pathways associated with tissue injury and complications

Antiviral potential of human IFN- subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities

Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host J o u r n a l P r e -p r o o f Journal Pre-proof responses, viral diversification, and drug interactions

Infection of human nasal epithelial cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles

Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 NSP1 protein., bioRxiv : the preprint server for biology

In utero gene expression in the slc39a8(neo/neo) knockdown mouse

STAR: ultrafast universal RNA-seq aligner

Rsem: accurate transcript quantification from rna-seq data with or without a reference genome

Improved metagenomic analysis with Kraken 2

Trimmomatic: a flexible trimmer for Illumina sequence data

Multiqc: summarize analysis results for multiple tools and samples in a single report

HBA-DEALS: accurate and simultaneous identification of differential expression and splicing using hierarchical bayesian analysis

An exploration of aspects of Bayesian multiple testing

Rejecting or accepting parameter values in bayesian estimation

Ontologizer 2.0-a multifunctional tool for GO term enrichment analysis and data exploration

The BioMart community portal: an innovative alternative to large, centralized data repositories

Viral interactions with components of the splicing machinery

Viral modulation of cellular RNA alternative splicing: A new key player in virus-host interactions?

RNA splicing: A new paradigm in host-pathogen interactions

Insights into the role of endoplasmic reticulum stress in infectious diseases

Regulation of ribosomal proteins on viral infection

Tinkering with translation: protein synthesis in virus-infected cells., Cold Spring Harbor perspectives in biology

SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation

Transcriptome-wide dynamics of RNA pseudouridylation

RMBase v2.0: deciphering the map of RNA modifications from epitranscriptome sequencing data

oRNAment: a database of putative RNA binding protein target sites in the transcriptomes of model species

CORUM: the comprehensive resource of mammalian protein complexes-2019

Proteomic analysis of human Nop56p-associated pre-ribosomal ribonucleoprotein complexes. Possible link between Nop56p and the nucleolar protein treacle responsible for Treacher Collins syndrome

Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2

Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible

editor-in-chief" of cytoplasmic innate immunity

Induction of a unique isoform of the NCOA7 oxidation resistance gene by interferon  -1b

Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells

The nature of the catalytic

Calsyntenin-1 mediates hepatitis C virus replication

GTPase-activating protein-binding protein 1 (G3BP1) plays an antiviral role against porcine epidemic diarrhea virus

Transforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter

Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling

Viruses exploit the function of epidermal growth factor receptor

The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication

The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation

Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: regulation of subcellular localization

Isotypic variants of the interferon-inducible transcriptional repressor IFI 16 arise through differential mRNA splicing

Interferon-inducible factor 16 is a novel modulator of glucocorticoid action

Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR

ADAR and immune silencing in cancer

The role of RNA editing by ADAR1 in prevention of innate immune sensing of self-RNA

Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase

Human ADAR1 prevents endogenous RNA from triggering translational shutdown

Evolutionary and structural analysis of SARS-CoV-2 specific evasion of host immunity

Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data

Preliminary structural data revealed that the SARS-CoV-2 b.1.617 variants RBD binds to ACE2 receptor stronger than the wild type to enhance the infectivity

Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation

The SARS-CoV-2 b.1.618 variant slightly alters the spike RBD-ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective

SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines